What it’s for
- Investigated for tissue repair
An experimental synthetic peptide promoted for injury recovery.
Purpose, evidence and practical considerations.
Most repair findings come from laboratory and animal work. They do not establish clinical benefit or safe dosing for oral or injected use in people.
Confidence: unsupported
Human safety, pharmacokinetics, immunogenicity, impurity risk, reproductive effects, cancer-related risk, and route-specific dosing are not adequately characterized. FDA flags compounded BPC-157 for potential immunogenicity and peptide-impurity concerns.
BPC-157 is a synthetic peptide promoted for tissue repair. Proposed angiogenic, nitric-oxide, and growth-factor pathways come mainly from laboratory and animal work; a validated human healing mechanism and effective dose have not been established.
Regulatory status: investigational peptide; not an FDA-approved drug or dietary supplement ingredient, and FDA has identified safety risks for compounded BPC-157
The evidence on this page does not automatically apply to:
How people use it, with their schedules, context and original sources.
infrequently over a couple of months
a skateboarding-related calf and nerve injury; he said it helped him contract the calf again
a hedge during surgical repair following a performance coach's recommendation
These share a protocol with this intervention. This does not establish that they work together or are suitable alternatives.